Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
7.24M
-
Shares change
-
+6.94M
-
Total reported value, excl. options
-
$84.4M
-
Value change
-
+$80.9M
-
Number of buys
-
42
-
Number of sells
-
-2
-
Price
-
$11.64
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2014
44 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2014.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.24M shares
of 50.5M outstanding shares and own 14.34% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (1.98M shares), DEERFIELD MANAGEMENT CO (1.42M shares), JPMORGAN CHASE & CO (749K shares), Sectoral Asset Management Inc (660K shares), FEDERATED INVESTORS INC /PA/ (574K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (275K shares), BlackRock Fund Advisors (227K shares), KENNEDY CAPITAL MANAGEMENT, INC. (200K shares), NORGES BANK (113K shares), and FMR LLC (100K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.